This is how a promising once-weekly HIV treatment could revolutionise medication adherence for patients, offering a simpler alternative to daily regimens.
ART iniitiation, managing comorbidities addressed for aging patients ...
Gilead's twice-yearly shot reduced HIV infections by 96% in a second large study, the company said. The data sets the stage for likely FDA approval of lenacapavir for HIV prevention. Shares rose 3% in ...
Through the lens of National Geographic photographer Rena Effendi, meet the network of organizations and people turning HIV ...
Simon Corcos, at Bradford Teaching Hospitals' HIV Clinic, has seen patients' outcomes transformed.
This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. A new sequential immunization strategy shows strong promise for an HIV vaccine, a ...
Aging with HIV comes with an increased risk of other health problems. Failing to get adequate care could undermine fighting the virus. (Story aired on Weekend Edition Saturday on June 15, 2024.) ...
This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. NAKURU, KENYA - 2026/03/26: A healthcare worker fills a syringe with a dose of lenacapavir, ...
For years, Philip Goulder has been obsessed with a particularly captivating idea: In the hunt for an HIV cure, could children hold the answers? Starting in the mid-2010s, the University of Oxford ...
SEATTLE – October 27, 2025 –Leaders in HIV research highlighted the critical role of that research has played in advancing HIV science over the past 40 years. In a commentary in Nature Medicine, they ...
Share on Pinterest A drug used to treat HIV infections can also effectively prevent them, a new clinical trial demonstrates. Image credit: luza studios/Getty Images. Human immunodeficiency virus (HIV) ...
In the early decades of the global response to HIV/AIDS, the focus was on saving lives. And rightly so: without antiretroviral treatment (ART), people lived less than a year, on average, from the time ...